ASTRODYNE LIMITED

Company number 13870350 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ASTRODYNE LIMITED - Analysis Report

Company Number: 13870350

Analysis Date: 2025-07-20 17:16 UTC

Financial Health Assessment for ASTRODYNE LIMITED


1. Financial Health Score: D

Explanation: ASTRODYNE LIMITED shows concerning signs of financial distress in its latest financial year (ending January 2024). The company has a negative net asset position (-£2,104), negative working capital (-£3,485), and a decline in cash reserves. These "symptoms" suggest the business is struggling to maintain a healthy financial equilibrium and may be facing liquidity challenges.


2. Key Vital Signs:

Metric 2024 Interpretation
Net Assets (Shareholders' Funds) -£2,104 Negative net assets indicate the company’s liabilities exceed assets, a symptom of financial strain or potential insolvency risk.
Net Current Assets (Working Capital) -£3,485 Negative working capital means current liabilities exceed current assets, signaling liquidity issues. The company may struggle to meet short-term obligations.
Cash at Bank £14,396 Cash has declined from £20,701 in 2023, indicating cash burn which could impair operational flexibility.
Current Liabilities £17,881 High current liabilities relative to cash and current assets are a warning sign of financial stress.
Fixed Assets (Tangible) £1,381 Fixed asset base is minimal but stable; depreciation is ongoing. Not a major factor in financial health here.
Share Capital £100 Very small equity base, typical for early-stage small companies but limits buffer against losses.
Turnover Not disclosed Lack of turnover data limits assessment of operational performance and profitability.

3. Diagnosis:

ASTRODYNE LIMITED exhibits "symptoms of distress" in the form of negative net assets and working capital. The company is relatively young (incorporated in 2022) and has experienced a deterioration in its financial position over its first two full financial years. The reduction in cash and increase in creditors suggest a tightening liquidity position. Negative shareholders’ funds reflect accumulated losses or insufficient capital injection.

The company’s financial records do not disclose turnover or profitability explicitly, but the absence of profit and loss account filing (as allowed under small companies regime) and the negative reserves imply operating losses or investment in growth without immediate returns.

The ownership and control are concentrated in one individual (Dr. Malcolm Paul Claus), which can allow for agile decision-making but also concentrates risk.

Overall, ASTRODYNE LIMITED is in a fragile financial state, with warning signs indicating potential cash flow constraints and solvency risks if the current trends continue.


4. Recommendations:

  • Improve Cash Flow Management: Prioritize converting receivables to cash faster, renegotiate payment terms with creditors, and closely monitor cash outflows to conserve liquidity.
  • Increase Capital Injection: Consider fresh equity or shareholder loans to bolster the balance sheet and improve net assets, creating a buffer against liabilities.
  • Operational Review: Conduct a thorough review of business operations to identify cost-saving opportunities and improve profitability. Without visible turnover data, focus on generating sustainable revenue streams.
  • Financial Reporting Transparency: Even though the company qualifies for exemption, providing more detailed financial info will help stakeholders make informed decisions and potentially attract investment.
  • Debt Restructuring: Explore options to restructure or defer short-term liabilities to ease immediate financial pressure.
  • Contingency Planning: Develop plans for downside scenarios, including potential insolvency procedures, to manage risks proactively.
  • Professional Advice: Engage financial and legal advisors to support turnaround strategies and compliance with regulatory requirements.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.